🇺🇸 Naltrexone pharmacotherapy in United States

Naltrexone pharmacotherapy (Naltrexone pharmacotherapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Naltrexone pharmacotherapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Naltrexone pharmacotherapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Naltrexone pharmacotherapy in United States?

Finnish Institute for Health and Welfare is the originator. The local marketing authorisation holder may differ — check the official source linked above.